Journal of Biological Chemistry

The Journal of Biological Chemistry (JBC) is a weekly peer-reviewed scientific journal that was established in 1905. Since 1925 it is published by the American Society for Biochemistry and Molecular Biology. It covers research in any area of biochemistry or molecular biology. The editor-in-chief is Herbert Tabor. All its articles are available free one year after publication. In press articles are available free on its website immediately after acceptance. The journal was established in 1905 by John Jacob Abel and Christian Archibald Herter, who also served as the first editors; the first issue appeared in October 1905. The location of the journal s editorial offices has included Cornell Medical College (until 1937), Yale University (1937–1958), Harvard University (1958–1967), and New York (from 1967). The journal is currently published by the American Society for Biochemistry and Molecular Biology (ASBMB) at the ASBMB offices in Rockville, Maryland. The following individuals have served as editors-in-chief: The editors of the Journal of Biological Chemistry have criticized the modern reliance upon the impact factor for ranking journals, noting that review articles, commentaries,

Publisher
American Society for Biochemistry and Molecular Biology
Country
United States
History
1905–present
Website
http://www.jbc.org/
Impact factor
5.328 (2010)

Some content from Wikipedia, licensed under CC BY-SA

HIV & AIDS

Hydrogen sulphide gas suppresses HIV infection

Researchers at the Indian Institute of Science (IISc) and their collaborators have identified a key role played by hydrogen sulfide (H2S) gas in suppressing the human immunodeficiency virus (HIV). Increased H2S was found ...

Medical research

New mouse model mimics earliest stages of Alzheimer's disease

Drug hunters hoping to prevent or delay the onset of Alzheimer's disease take note—a new mouse model developed at RIKEN offers a powerful platform for evaluating potential therapies designed to combat the neurodegenerative ...

Oncology & Cancer

CAR-T immunotherapy could be improved to kill solid tumors

Immunotherapy, which harnesses the power of the body's immune system to fight disease, is gaining huge traction in treating cancer. Chief among cancer immunotherapies is a treatment known as CAR-T, or chimeric antigen receptor ...

Neuroscience

Low levels of a simple sugar: A new biomarker for severe MS?

Multiple sclerosis, or MS for short, manifests itself slightly differently in each person—which is why some call it "the disease of a thousand faces." Arguably the worst manifestation of MS is its chronic progressive form. ...

page 1 from 20